15 days ago
OCS
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-27 - 2024-03-27 | Strong Buy |
Viking Therapeutics IncVKTX | +428.83% | $11.83 | $62.56 | 2023-03-16 - 2024-03-15 | Strong Buy |
Palvella Therapeutics IncPVLA | +307.84% | $27.93 | $113.91 | 2025-03-25 - 2026-03-19 | Strong Buy |
Prometheus Biosciences IncRXDX | +276.85% | $51.35 | $193.51 | 2022-10-31 - 2023-04-17 | Strong Buy |
Viking Therapeutics IncVKTX | +257.67% | $14.22 | $50.86 | 2023-08-07 - 2024-08-07 | Strong Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oculis Holding AgOCS | 3 | Strong Buy | $50.00 | +97.08% | Maintains | 15 days ago |
Evolus IncEOLS | 2 | Strong Buy | $17.00 | +249.79% | Maintains | 2 months ago |
Trevi Therapeutics IncTRVI | 1 | Strong Buy | $18.00 | +68.22% | Maintains | 3 months ago |
Supernus Pharmaceuticals IncSUPN | 5 | Hold | $55.00 | +12.61% | Maintains | 3 months ago |
Regenxbio IncRGNX | 3 | Strong Buy | $45.00 | +438.28% | Maintains | 3 months ago |
Mineralys Therapeutics IncMLYS | 2 | Strong Buy | $52.00 | +123.37% | Maintains | 3 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $50.00 | +75.87% | Maintains | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 4 | Strong Buy | $48.00 | +167.11% | Maintains | 3 months ago |
Ligand Pharmaceuticals IncLGND | 2 | Strong Buy | $230.00 | +9.77% | Maintains | 3 months ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $90.00 | +78.36% | Maintains | 3 months ago |
Palvella Therapeutics IncPVLA | 3 | Strong Buy | $145.00 | +27.29% | Maintains | 4 months ago |
Altimmune IncALT | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Inventiva SaIVA | 4 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Revance Therapeutics IncRVNC | 2 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Kamada LtdKMDA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Phathom Pharmaceuticals IncPHAT | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Viking Therapeutics IncVKTX | 6 | Strong Buy | $80.00 | N/A | Reiterates | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $230.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $172.50 | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 4 | Strong Buy | $336.00 | N/A | Reiterates | 3 years ago |
Kyntra Bio IncKYNB | 3 | Hold | $275.00 | N/A | Downgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 2 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 4 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Clearside Biomedical IncCLSDQ | 1 | Strong Buy | $120.00 | N/A | Upgrades | 3 years ago |
Evofem Biosciences IncEVFM | 2 | Hold | $0.50 | N/A | Downgrades | 3 years ago |
Iveric Bio IncISEE | 2 | Strong Buy | $35.00 | N/A | Maintains | 4 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Hold | $15.25 | N/A | Downgrades | 4 years ago |
Elicio Therapeutics IncELTX | 3 | Hold | $15.00 | N/A | Downgrades | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Radius Health IncRDUS1 | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Therapeuticsmd IncTXMD | 3 | Strong Buy | $750.00 | N/A | Maintains | 6 years ago |
Durect CorpDRRX | 4 | Hold | $21.00 | N/A | Maintains | 7 years ago |
Zogenix IncZGNX | 2 | Strong Buy | $61.00 | N/A | Maintains | 7 years ago |
Endo International PLCENDPQ | 2 | Hold | $17.00 | N/A | Maintains | 8 years ago |
Innocoll Holdings PLCINNL | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |